MedPath

Bolus dosages of Norepinephrine,phenylephrine and ephedrine for spinal induced Hypotension in parturients undergoing elective caesarean section.

Not Applicable
Conditions
Health Condition 1: O30-O48- Maternal care related to the fetus and amniotic cavity and possible delivery problems
Registration Number
CTRI/2020/06/025626
Lead Sponsor
S NIJALINGAPPA MEDICAL COLLEGE AND HSK HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Age between 18 to 35 years.

2.Body mass index <=30 kg/m2

3.Singleton pregnancies at term scheduled for

elective cesarean section under

spinal anesthesia

Exclusion Criteria

1.ASA status III and IV.

2.Emergency caesarean section.

3.Active labour.

4.High risk pregnancies ( Intrauterine growth

retardation, preeclampsia)

5.Maternal cardiovascular and pulmonary

diseases.

6.Foetal abnormalities

7.History of diabetes excluding Gestational diabetes

8.Patients on MAO inhibitors and TCA.

9.Patients allergic to any of the medications used in study.

10.If block(anesthesia) level achieved higher than T4.

11.Height less than 140cm or more than 180cm

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the efficacy(potency) and safety of bolus dosages of Norepinephrine, Phenylephrine, Ephedrine in elective parturient women to treat hypotension during caesarean delivery under spinal anaesthesia. <br/ ><br>Timepoint: Number of blous dosages of drug needed to treat maternal hypotension,number of episodes of maternal hypotension occurred before delivery of baby and fetal outcomes immediately after birth (to prove most potent and effective drug to treat maternal hypotension intra operatively 1st 12 minutes following performing spinal anaesthesia)
Secondary Outcome Measures
NameTimeMethod
1.Assessing number of episodes of bradycardia (HR less than60 bpm), tachycardia (HR less than 120 bpm) hypertension(SBP greater than20% of baseline) and number of hypotension episodes occurred. <br/ ><br>2.Assessing number of vasopressor boluses required to treat post spinal hypotension <br/ ><br>3. Assessing maternal side effects like nausea, vomiting, dizziness and shivering. <br/ ><br>4.Assessing neonatal outcome, including Apgar scores at one minute and five minutes, umbilical artery blood gas analysis and pH. <br/ ><br>Timepoint: 2 hours
© Copyright 2025. All Rights Reserved by MedPath